Steric Stabilization of Lipid Nanoparticles by Sequence-Defined Polymer−Lipids Enhances Gene Expression
Open Access
- 3 October 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 9 (41) , 19525-19536
Abstract
Polyethylene glycol (PEG) conjugated lipids are frequently used for the design of lipid nanoparticles (LNPs) in the field of gene therapy. However, conventional PEG−lipids contain a distribution of polymer chain lengths. To overcome this limitation, we have prepared a structurally defined PEG-alternative polymer-lipid platform synthesized via solid-phase peptide synthesis (SPPS), enabling precise control over polymer chain length and lipid anchor identity. A library of chain-length-defined poly(succinamide−4,7,10-trioxatridecane)n−lipid (poly(SA-TTD)n-lipid) conjugates, with hydrophilic polymer segments ranging from 923 to 2133 g/mol and varied lipid tails, was synthesized and formulated into DNA-loaded LNPs using microfluidic mixing. Systematic variation of polymer length and lipid tail structure revealed their distinct influence on NP size, colloidal stability, and DNA encapsulation efficiency. All formulations produced particles with narrow size distributions (PDI <0.2) with efficient DNA association. In vitro studies demonstrated that selected PEG-alternative LNPs significantly enhanced transfection efficiency compared to PEG2000-containing controls, achieving up to 18-fold higher transgene expression. Notably, these formulations also exhibited an approximately fourfold higher endosomal escape-associated signal. In vivo evaluation in zebrafish larvae (ZFL) further confirmed efficient systemic circulation and superior transgene expression without apparent toxicity. In summary, this work establishes a modular, sequence-defined polymer-lipid platform that provides a promising PEG alternative for LNP-mediated gene delivery.Keywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CRSII222794 / 1)
This publication has 45 references indexed in Scilit:
- A Non‐Antigenic Randomized Polyethylene Glycol/Poly(2‐Phenyl‐2‐Oxazine)‐Based Drug Delivery PlatformMacromolecular Rapid Communications, 2025
- Overcoming PEG Antigenicity: Statistical PEG Isomers Reduce Antibody BindingAdvanced Science, 2025
- Polyglycerol‐Based Lipids: A Next‐Generation Alternative to PEG in Lipid Nanoparticles for Advanced Drug Delivery SystemsMacromolecular Rapid Communications, 2025
- Influence of structural variations in polysarcosine functionalized lipids on lipid nanoparticle‐mediated mRNA deliveryJournal of Polymer Science, 2024
- Clinical progress of nanomedicine-based RNA therapiesBioactive Materials, 2021
- Zebrafish Embryos Allow Prediction of Nanoparticle Circulation Times in Mice and Facilitate Quantification of Nanoparticle–Cell InteractionsSmall, 2020
- Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticalsAdvanced Drug Delivery Reviews, 2020
- Zebrafish as a preclinical in vivo screening model for nanomedicinesAdvanced Drug Delivery Reviews, 2019
- PEGylation as a strategy for improving nanoparticle-based drug and gene deliveryAdvanced Drug Delivery Reviews, 2016
- Color test for detection of free terminal amino groups in the solid-phase synthesis of peptidesAnalytical Biochemistry, 1970